IT1054620B - Poli(idrossimetilene)idroinsolubile biologicamente attivo procedimento per la sua preparazione e suo impiego nella cromatografia per affinita - Google Patents

Poli(idrossimetilene)idroinsolubile biologicamente attivo procedimento per la sua preparazione e suo impiego nella cromatografia per affinita

Info

Publication number
IT1054620B
IT1054620B IT22967/75A IT2296775A IT1054620B IT 1054620 B IT1054620 B IT 1054620B IT 22967/75 A IT22967/75 A IT 22967/75A IT 2296775 A IT2296775 A IT 2296775A IT 1054620 B IT1054620 B IT 1054620B
Authority
IT
Italy
Prior art keywords
poli
hydroxymethylene
affinity
chromatography
procedure
Prior art date
Application number
IT22967/75A
Other languages
English (en)
Italian (it)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742421789 external-priority patent/DE2421789C3/de
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of IT1054620B publication Critical patent/IT1054620B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT22967/75A 1974-05-06 1975-05-02 Poli(idrossimetilene)idroinsolubile biologicamente attivo procedimento per la sua preparazione e suo impiego nella cromatografia per affinita IT1054620B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742421789 DE2421789C3 (de) 1974-05-06 Biologisch aktive Produkte und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
IT1054620B true IT1054620B (it) 1981-11-30

Family

ID=5914739

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22967/75A IT1054620B (it) 1974-05-06 1975-05-02 Poli(idrossimetilene)idroinsolubile biologicamente attivo procedimento per la sua preparazione e suo impiego nella cromatografia per affinita

Country Status (16)

Country Link
JP (1) JPS599153B2 (cg-RX-API-DMAC10.html)
AT (1) AT338417B (cg-RX-API-DMAC10.html)
BE (1) BE828776A (cg-RX-API-DMAC10.html)
CA (1) CA1063049A (cg-RX-API-DMAC10.html)
CH (1) CH630410A5 (cg-RX-API-DMAC10.html)
DK (1) DK196175A (cg-RX-API-DMAC10.html)
ES (1) ES437153A1 (cg-RX-API-DMAC10.html)
FI (1) FI60216C (cg-RX-API-DMAC10.html)
FR (1) FR2270266B1 (cg-RX-API-DMAC10.html)
GB (1) GB1512651A (cg-RX-API-DMAC10.html)
IE (1) IE41040B1 (cg-RX-API-DMAC10.html)
IT (1) IT1054620B (cg-RX-API-DMAC10.html)
LU (1) LU72407A1 (cg-RX-API-DMAC10.html)
NL (1) NL181782C (cg-RX-API-DMAC10.html)
NO (1) NO144672C (cg-RX-API-DMAC10.html)
SE (2) SE427086B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2552510C3 (de) * 1975-11-22 1981-02-19 Behringwerke Ag, 3550 Marburg Biologisch aktive Verbindungen und Verfahren zu ihrer Herstellung
DE60329126D1 (de) 2002-02-20 2009-10-15 Beth Israel Hospital Konjugate mit biologisch abbaubarem polymer und verwendung dafür
JP6476934B2 (ja) * 2015-02-02 2019-03-06 東ソー株式会社 新規重合体、およびそれを有する細胞培養基材

Also Published As

Publication number Publication date
IE41040B1 (en) 1979-10-10
LU72407A1 (cg-RX-API-DMAC10.html) 1977-02-09
NL7505152A (nl) 1975-11-10
BE828776A (fr) 1975-11-06
FR2270266B1 (cg-RX-API-DMAC10.html) 1979-03-16
FI751299A7 (cg-RX-API-DMAC10.html) 1975-11-07
FR2270266A1 (cg-RX-API-DMAC10.html) 1975-12-05
DE2421789A1 (de) 1975-11-13
DK196175A (da) 1975-11-07
CA1063049A (en) 1979-09-25
NL181782C (nl) 1987-11-02
SE7505275L (sv) 1975-11-07
NL181782B (nl) 1987-06-01
DE2421789B2 (de) 1976-10-07
SE427086B (sv) 1983-03-07
NO751599L (cg-RX-API-DMAC10.html) 1975-11-07
FI60216B (fi) 1981-08-31
ES437153A1 (es) 1977-04-16
JPS50155679A (cg-RX-API-DMAC10.html) 1975-12-16
AT338417B (de) 1977-08-25
GB1512651A (en) 1978-06-01
FI60216C (fi) 1981-12-10
ATA342275A (de) 1976-12-15
SE444947B (sv) 1986-05-20
AU8081875A (en) 1976-11-11
NO144672C (no) 1981-10-14
NO144672B (no) 1981-07-06
JPS599153B2 (ja) 1984-02-29
CH630410A5 (en) 1982-06-15
IE41040L (en) 1975-11-06

Similar Documents

Publication Publication Date Title
IT1162842B (it) Composizione farmaceutica topica per uso oftalmico e sua applicazione
IT7969144A0 (it) Composizione ammorbidente per tessuti e procedimento per la sua preparazione
IT1207323B (it) Composizione di gel interpolimero idrosolubile limpido,in particolareper uso cosmetico e procedimento di preparazione
IT7969021A0 (it) Torba laminare per uso agricolo eprocedimento per la sua fabbricazione
IT1070265B (it) Composizione antitraspirante solida e procedimento per la sua preparazione
IL48484A0 (en) 5-hydroxypropionylamino-2,4,6-triiodo-isophthalic acid bis-(dihydroxypropyl-amides),their preparation and use as x-ray contrast agents
IT7968443A0 (it) Procedimento per la preparazione del cloruro di cianurile allo stato solido
IT1065789B (it) Procedimento e dispositivo per la determinazione di quantita'di postdosatura
IT1153294B (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle
IT1113390B (it) Copolimero ad innesto utile nella elettrodeposizione
IT976871B (it) Composizione da impiegarsi nella saldatura metodo di sua prepa razione e suo impiego
IT1115268B (it) Perfezionamenti nella radiografia
IT7852075A0 (it) Vaccino pneumococcico e suo procedimento di preparazione
IT1178886B (it) Copolimero alliloligosaccarde acrilico salificato procedimento per la sua preparazione e suo impiego come superassorbente
IT1047444B (it) Lega di alluminio elettrochimicamente attiva e procedimento per la sua preparazione e per il suo impiego
IT1062237B (it) Agente di scansione per scintigrafia e procedimento per la sua preparazione
IT1059793B (it) Composizione aggiunta nell asciugatoio e metodo di suo impiego
IT1197427B (it) Metodo di formulazione di leghe metalliche ad uso odontoiatrico e complesso di leghe cosi' ottenute
IT1116608B (it) Antitraspirante e procedimento per la sua preparazione
IT1054620B (it) Poli(idrossimetilene)idroinsolubile biologicamente attivo procedimento per la sua preparazione e suo impiego nella cromatografia per affinita
IT1152477B (it) Preparato bituminoso,procedimento per la sua fabbricazione e suo impiego
IT8248505A0 (it) Agente ausiliario di macinazione per cementi idraulici e suo procedimento di preparazione
IT1079025B (it) Perfezionamento nella preparazione di eteri
IT1090735B (it) Composizione antibatterica per uso orale e metodo per la sua preparazione
IT1126572B (it) Derivato del paracetamol,procedimento per la sua preparazione e suo impiego nel campo terapeutico